Branded Generics Market Size, Business Intelligence With Lupin Pharmaceuticals, Abbott, STADA, Novartis, Aurobindo Pharma, Allergan, Teva Pharmaceuticals, Aspen Pharma, Cipla, Mylan, Sun Pharmaceutical Sdn Bhd
The global branded generics market report endows with the basic information about industry, definition, classification, application, industry chain structure, industry overview and international market analysis. This branded generics market report also gives description about the complete market analysis with inputs from industry experts. It includes the detailed profiles for the branded generics market’s major manufacturers and importers who are influencing the market. The report also recognizes and analyses the emerging trends along with major drivers, challenges and opportunities in the Market. branded generics report also gives widespread study about different market segments and regions.
Global branded generics market is expected to rise from its initial estimated value of USD 232.83 billion in 2018 to a projected value of USD 421.15 billion by 2026, registering a CAGR of 7.69% in the forecast period of 2019-2026. This rise in market value can be attributed to growing need for cheaper treatment options and pharmaceutical drugs required by patients.
Get Free Sample of This Market Information: databridgemarketresearch.com/request-a-sample/?dbmr=globa...
Market Definition: Global Branded Generics Market
Branded generic can be defined as those pharmaceutical drugs that have been re-released with a different brand name. These drugs are produced by various pharmaceutical manufacturing companies as the patent of this drug has already expired and the generic drugs are sold at a lower cost. Even though, there isn’t any difference in the quality or manufacturing process of the drug.
Key Market Competitors: Global Branded Generics Market
Teva Pharmaceutical Industries Ltd.; Zydus Cadila; Hetero; AstraZeneca; Mylan N.V.; Novartis AG; Pfizer Inc.; GlaxoSmithKline plc; Aspen Holdings; Bausch Health; Eris Lifesciences Limited; Par Pharmaceutical; Sanofi; Apotex Inc.; Dr. Reddy’s Laboratories Ltd.; Abbott; Sun Pharmaceutical Industries Ltd.; Lupin Pharmaceuticals, Inc.; ALLERGAN; Stada Arzneimittel; Cipla Inc. and EVA PHARMA are few of the major competitors currently working in the branded generics market.
· Growth in the number of patents expired and expiring for the branded drugs; this factor is one of the major factors driving the market growth
· Growth in the incidents and population suffering from chronic diseases and disorders; this factor is expected to drive the market growth
· Lack of penetration associated with the number of generic drugs worldwide; this factor is expected to act as a restraint to the market growth
Key Developments in the Market:
· In January 2019, Hetero announced the launch of generic version of “lapatinib” in India, which will be commercialized as “Hertab” by Hetero Healthcare Ltd.
· In February 2018, Hetero announced the launch of a generic fixed-dose combination (FDC) drug of “emtricitabine” and “tenofovir alafenamide” in India. The product has already been approved by Drug Controller General of India (DCGI) will be commercialized as “Tafero-EM” by Hetero Healthcare Ltd.
· In November 2017, Eris Lifesciences Limited announced that they had agreed to acquire the branded generics division of Strides Shasun Limited. This acquisition will help in establishing Eris Lifesciences Limited as one of the top ten companies worldwide for Central Nervous System treatment segment.
Get TOC For Full Analysis Of Report: databridgemarketresearch.com/toc/?dbmr=global-branded-gen...
Competitive Analysis: Global Branded Generics Market
Global branded generics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of branded generics market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Segmentation: Global Branded Generics Market
· By Product Type
o Value-Added Branded Generics
o Trade (Brand) Named Generics
· By Therapeutic Application
o Cardiovascular Diseases
o Gastrointestinal Diseases
o Dermatology Diseases
o Analgesics & Anti-Inflammatory
· By Drug Class
o Alkylating Agents
o Lipid Lowering Drugs
· By Consumption Type
· By Distribution Channel
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
· By Geography
o North America
o South America
· Rest of South America
· United Kingdom
· Rest of Europe
· South Korea
· Rest of Asia Pacific
o Middle East & Africa
· South Africa
· Saudi Arabia
· United Arab Emirates
· Rest of Middle East & Africa
Reasons to Purchase this Report
· Current and future of global branded generics market outlook in the developed and emerging markets
· The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
· Regions/Countries that are expected to witness the fastest growth rates during the forecast period
· The latest developments, market shares, and strategies that are employed by the major market players
Customization of the Report:
· All segmentation provided above in this report is represented at country level
· All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)
Want Full Report? Enquire Here: databridgemarketresearch.com/inquire-before-buying/?dbmr=...
Data Bridge Market Research
Toll Free: +1-888-387-2818
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing email@example.com . We are content with our glorious 99.9 % client satisfying rate.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Branded Generics Market Size, Business Intelligence With Lupin Pharmaceuticals, Abbott, STADA, Novartis, Aurobindo Pharma, Allergan, Teva Pharmaceuticals, Aspen Pharma, Cipla, Mylan, Sun Pharmaceutical Sdn Bhd here
News-ID: 1773342 • Views: 4644
More Releases from Data Bridge Market Research
Global App Analytics Market Market To Grow at a CAGR of 22.61% by 2026 Profiling …
Global App Analytics Market is driven by increasing demand for smart phones, which is projecting a rise in estimated value from USD 1.13 billion in 2018 to an estimated value of USD 5.76 billion by 2026, registering a CAGR of 22.61% in the forecast period of 2019-2026. App analytics helps in connecting the developer tool to get the information of user that how the user is interacting with the application. The
Global Consumer IAM Market is growing at a highest CAGR of 16.75% Industry Analy …
The Global Consumer IAM Market is growing at a CAGR of 16.75% during the forecast period of 2019 to 2026. Market Definition: Consumer IAM deals with relationships that are broader and shallower, and much more loosely coupled than those in Customer IAM scenarios. These use cases are typically driven by the marketing organization – to get the right frame of reference. The main drivers boosting the growth of this market
Global Spunbond Nonwovens Market Growth, Trends and Forecast to 2026 | Top Key P …
The report includes forecasts and analysis for the Global Spunbond Nonwovens Market at global and regional level. It provides historic data covering 2016, base data covering 2017 along with a forecast from 2019 to 2026 based on revenue sales, import and export. The study includes drivers and restraints for the Global Spunbond Nonwovens Market with the help of SWOT analysis, along with the impact they have on the demand over
Anti-Slip Additives Marke Global Opportunity Analysis and Industry Forecast, 201 …
Global Anti-Slip Additives Market is expected to rise from its initial estimated value of USD 356.01 million in 2018 to an estimated value of USD 505.51 million by 2026, registering a CAGR of 4.48% in the forecast period of 2019-2026. This rise in market value can be attributed to the growing urbanization and industrialization globally. The report is generated based on the market type, size of the organization, availability on-premises and
More Releases for Brand
MilitaryPlaques.Com Brand New Website
Indianapolis--On February 2011 launched a new website for MilitaryPlaques.COM, an online merchant of mahogany wood products. The new site is programmed, conceptualized and designed for easier and more secure online shopping. With the use of the most advance e-commerce sofrware platform and Content Management System CMS, MilitaryPlaques.Com has able to develop a website that responds to customers' demand for an easier user interface shopping cart. The new website homepage is designed to
Conference on Korea’s Nation Brand
Participants engaged in a vital discussion on the impact of the upcoming G20 Seoul Summit and North Korea’s leadership succession on South Korea’s nation brand - The Presidential Council on Nation Branding (Chairwoman: Lee Bae-Yong) hosted a Conference on Korea’s Nation Brand on Wednesday, October 27 from 14:00 to 17:00 at the Convention Hall of the Grand Hilton Seoul. Discussions were held on the impact of the upcoming G20 Seoul Summit
Sea Scapes by Bruce Brand
Scheduled to run from October 26 through November 15, 2007 Opening Reception: Thursday, November 1, 2007, 6-8 pm Gallery Location: 530 West 25th Street, Chelsea, New York 10001 The public is invited to participate in the event Bruce Brand's art has always been about inner struggle and a search for understanding and peace. In the 1960s his work was created out of anger, confusion, and disillusionment against the backdrop of the war in Vietnam.
Brand Becomes a Hit
‘Brand becomes a hit’ – this was the title of round-table discussion in the context of ‘PeterFood’ exhibition (Saint-Petersburg, Russia) which was held on 8 of November. The event’s organizers invited the founder of the branding agency ‘Zarkin and Partners’ Gene Zarkin who shared the secrets of successful brand development. ‘PeterFood’ is the largest food exhibition in the North-West region of Russia which has been held annually for 15 years.
Taste of brand
On the 3 of November on his way to Bishkek (Kirgizia) the founder of the branding agency ‘Zarkin and Partners’ Gene Zarkin (Saint-Petersburg, Russia) held a branding seminar in the context of the WorldFood 2006 exhibition (Almaty, Kazakhstan). WorldFood is the annual exhibition dedicated to the food industry, the 3rd biggest in Kazakhstan. This year more than 300 companies from 27 countries presented their products and services there. Both the exponents (representatives
Generic Brand Acetaminophen Recall
The U.S. Food and Drug Administration (FDA) is informing the public to a recall by Perrigo Company (Perrigo) of Allegan, Michigan for 383 lots of acetaminophen 500mg caplets manufactured and distributed under various generic or store brands due to small metal fragments found in the acetaminophen. An estimated 11 million bottles are affected by this recall. For a list of acetaminophen recall, see www.fda.gov/oc/po/firmrecalls/perrigo/perrigobatchlist.html. Consumers can determine if they are